Surrey Bancorp Reports Second Quarter Net Income of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Surrey Bancorp Reports Second Quarter Net Income of $800,843

MOUNT AIRY, NC--(Marketwired - Jul 25, 2013) - Surrey Bancorp (the "Company"), ( PINKSHEETS : SRYB ), the holding company for Surrey Bank & Trust, today reported earnings for the second quarter of 2013.

For the quarter ended June 30, 2013, net income totaled $800,843 or $0.19 per fully diluted share, compared with $367,581 or $0.09 per fully diluted common share earned during the second quarter of 2012.

Earnings for the three months ended June 30, 2013, are approximately 117.9 percent higher than for the same period in 2012. The increase results from a reduction in the provision for loan losses and an increase in noninterest income. The provision for loan losses decreased from $671,770 in the second quarter of 2012 to a provision of $93,402 in 2013. This decrease is due to a reduction in net loan charge offs from $771,374 in the second quarter of 2012 to $4,064 in the second quarter of 2013. At June 30, 2013, the percentage of loans receiving pass credit risk grades was 98.3 percent, compared to 98.2 percent at December 31, 2012 and 97.9 percent at June 30, 2012. Credit quality was further enhanced by an increase in loans carrying government guarantees. At June 30, 2013, the guaranteed portion of loans equaled 25.1 percent of total loans compared to 24.4 percent at December 31, 2012 and 22.5 percent at June 30, 2012. Noninterest income increased due to a gain on the sale of a government guaranteed loan. The gain of $229,130 increased noninterest income from $572,251 in the second quarter 2012 to $796,643 in 2013.

Net interest income decreased from $2,294,168 in the second quarter of 2012 to $2,251,138 in 2013. Asset yields decreased from 5.27 percent to 4.83 percent from 2012 to 2013 partially due to the change in average earning asset mix from higher yielding loans to lower yielding deposits in other banks. Loan yields also decreased from 6.01 percent in the second quarter of 2012 to 5.71 percent in the second quarter of 2013. Loan yields fell due to the prolonged low rate environment and competition. A reduction in the cost of deposits from the second quarter of 2012 to 2013 was unable to offset the lower asset yields. The cost of funds decreased from 0.89 percent in the second quarter of 2012 to 0.80 percent in the second quarter of 2013. Noninterest expenses increased slightly from $1,623,208 in the second quarter of 2012, to $1,678,757 in 2013. Salaries and employee benefits accounted for most of the change increasing from $861,138 in 2012 to $910,375 in 2013. This increase was primarily due to normal salary adjustments

Loan loss reserves were $3,431,373 or 1.87 percent of total loans as of June 30, 2013. Non-performing assets were 1.55 percent of total assets at June 30, 2013, compared to 1.94 percent on that date in 2012. At June 30, 2013, the allowance for loan loss reserves equals 91 percent of impaired and non-performing assets, net of government guarantees.

Total assets were $234,574,115 as of June 30, 2013, an increase of 6.5 percent from $220,164,691 reported as of June 30, 2012. Total deposits were $190,147,848 at quarter-end 2013, a 6.4 percent increase from the $178,640,380 reported at the end of the second quarter of 2012. Net loans increased 3.0 percent to $180,450,435, compared to $175,177,109, at June 30, 2012.

Net income for the six months ended June 30, 2013, was $1,452,619 or $0.35 per diluted share, compared to $1,031,638 or $0.25 per diluted share, for the same period in 2012.

About Surrey Bancorp Surrey Bancorp is the bank holding company for Surrey Bank & Trust (the "Bank") and is located at 145 North Renfro Street, Mount Airy, North Carolina. The Bank operates full service branch offices at 145 North Renfro Street, 1280 West Pine Street and 2050 Rockford Street in Mount Airy. Full-service branch offices are also located at 653 South Key Street in Pilot Mountain, North Carolina, and 940 Woodland Drive in Stuart, Virginia.

Surrey Bank & Trust is engaged in the sale of insurance through its wholly owned subsidiary, SB&T Insurance, located at 199 North Renfro Street in Mount Airy. The Bank also owns Surrey Investment Services, Inc., which provides full-service brokerage and investment services through an association with LPL Financial, and Freedom Finance, LLC, a sales finance company located at 165 North Renfro Street in Mount Airy.

Surrey Bank & Trust can be found online at www.surreybank.com .

Non-GAAP Financial Measures This report refers to the overhead efficiency ratio, which is computed by dividing non-interest expense by the sum of net interest income and non-interest income. This is a non-GAAP financial measure that we believe provides investors with important information regarding our operational efficiency. Comparison of our efficiency ratio with those of other companies may not be possible, because other companies may calculate the efficiency ratio differently. Such information is not in accordance with generally accepted accounting principles in the United States (GAAP) and should not be construed as such. Management believes such financial information is meaningful to the reader in understanding operating performance, but cautions that such information not be viewed as a substitute for GAAP. Surrey Bancorp, in referring to its net income, is referring to income under GAAP.

Forward Looking Statements Information in this press release contains "forward-looking statements." These statements involve risks and uncertainties that could cause actual results to differ materially, including without limitation, the effects of future economic conditions, governmental fiscal and monetary policies, legislative and regulatory changes, the risks of changes in interest rates and the effects of competition. Additional factors that could cause actual results to differ materially are discussed in Surrey Bancorp's recent filings with the Securities and Exchange Commission, included but not limited to its Annual Report on Form 10-K and its other periodic reports .

SURREY BANCORP
CONSOLIDATED FINANCIAL HIGHLIGHTS
(Dollars in thousands, except per share amounts)
 
 
  June 30, 2013     December 31, 2012     June 30, 2012
  (unaudited)           (unaudited)  
Total assets $ 234,574     $ 229,912     $ 220,165
Total loans   183,882       176,981       178,979
Investments   34,980       37,318       22,984
Deposits   190,148       187,823       178,640
Borrowed funds   7,750       7,750       7,750
Stockholders' equity   33,599       32,237       31,204
Non-performing assets to total assets   1.55 %     1.84 %     1.94 %
Loans past due more than 90 days to total loans   0.35 %     0.39 %     0.41 %
Allowance for loan losses to total loans   1.87 %     1.93 %     2.12 %
Book value per common share $ 8.39     $ 8.01     $ 7.72
                     
                     
SURREY BANCORP  
CONSOLIDATED FINANCIAL HIGHLIGHTS  
(Dollars in thousands, except per share amounts)  
   
    For the Three Months Ended June 30,     For the Six Months Ended June 30,  
    2013     2012     2013     2012  
Interest income   $ 2,648     $ 2,716     $ 5,293     $ 5,486  
Interest expense     397       422       782       872  
Net interest income     2,251       2,294       4,511       4,614  
Provision for loan losses     93       672       136       739  
Net interest income after provision for loan losses     2,158       1,622       4,375       3,875  
Noninterest income     797       572       1,455       1,232  
Noninterest expense     1,679       1,623       3,520       3,477  
Net income before taxes     1,276       571       2,310       1,630  
Provision for income taxes     475       203       857       599  
Net income     801       368       1,4533       1,031  
Preferred stock dividend declared     46       46       91       91  
Net income available to common shareholders   $ 755     $ 322     $ 1,362     $ 940  
Basic net income per share   $ 0.21     $ 0.09     $ 0.38     $ 0.27  
Diluted net income per share   $ 0.19     $ 0.09     $ 0.35     $ 0.25  
Return on average total assets 1 ?     1.36 %     0.66 %     1.23 %     0.92 %
Return on average total equity 1 ?     9.62 %     4.74 %     8.82 %     6.70 %
Yield on average interest earning assets     4.83 %     5.27 %     4.88 %     5.29 %
Cost of funds     0.80 %     0.89 %     0.79 %     0.92 %
Net yield on average interest earning assets     4.11 %     4.45 %     4.16 %     4.45 %
Overhead efficiency ratio     55.08 %     56.63 %     59.01 %     59.47 %
Net charge-offs (recoveries)/average loans     0.00 %     0.43 %     0.06 %     0.46 %

1 Annualized for all periods presented.

For additional information, please contact Ted Ashby CEO or Mark Towe CFO (336) 783-3900

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 5

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 8

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Korean Heritage Through Captivating Video Journey

Updated Category News Views 146

A New Adventure in Korean Heritage The 2024 Visit Korean Heritage Campaign has launched a spectacular promotional video titled "Time Traveler's Korea – Changdeokgung Palace Episode," highlighting the incredible beauty and significance of Changdeokgung Palace. The video is presented by actress Cho Boah, who serves as the official ambassador for Korean Heritage this year....

Continue Reading
Prospera Energy Updates on Enhanced Production Strategies

Updated Category News Views 275

Prospera Energy Enhances Production and Operational Efficiency Prospera Energy Inc. (TSX.V: PEI) has made substantial progress in its operations by focusing on optimizing production in its heavy oil properties. With an emphasis on both immediate production increases and long-term reliability, the company has successfully completed several key initiatives recently that...

Continue Reading
Upcoming Investor Conferences for WillScot Holdings in December

Updated Category News Views 146

WillScot Holdings Corporation's Upcoming Investor Conferences WillScot Holdings Corporation, renowned for its innovative temporary space solutions, has announced its schedule for upcoming investor conferences. This announcement underscores WillScot's commitment to keeping investors informed and engaged in the company's strategic developments. Bank of America Leveraged...

Continue Reading
iLearningEngines Investigates Short-Seller Allegations Thoroughly

Updated Category News Views 48

iLearningEngines Responds to Misleading Claims iLearningEngines, Inc. (NASDAQ: AILE) is taking proactive steps by establishing a Special Committee to investigate recent allegations presented in a short-seller report. This move reflects the company’s dedication to transparency and its commitment to protecting the interests of its shareholders. Creation of the Special...

Continue Reading
MetLife Stadium Raises the Bar for Security Technology

Updated Category News Views 466

MetLife Stadium Raises the Bar for Security Technology Axis Communications, a leader in the video surveillance and network device industry, has collaborated closely with MetLife Stadium to bring forth an advanced surveillance solution that promises to elevate the venue's security measures significantly. With a focus on augmenting their capabilities, this innovative...

Continue Reading